Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 601–700 of 1,000
Dao, L. N., Jacobs, J. R., Kuebler, P., Bakker, E., & Lippe, B. M. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.07.002 · Cited by 8
“Subsequently, adults with GH deficiency have also been shown to benefit from rhGH replacement therapy [2].”
BackgroundVarewijck, A. J., Lamberts, S. W. J., Neggers, S. J. C. M. M., Hofland, L. J., & Janssen, J. A. M. J. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2901 · Cited by 8
Boguszewski, C. L., de Lacerda, C. S., Filho, L. D. L., de Carvalho, J. Â. R., & Boguszewski, M. C. D. S. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900006 · Cited by 8
Lipworth, W. L., Ho, K. K. Y., Kerridge, I., & Day, R. O. (2012) · The Medical Journal of Australia · doi:10.5694/mja11.11572 · Cited by 9
Thankamony, A., Capalbo, D., Jönsson, P., Simpson, H., & Dunger, D. B. (2016) · Hormone Research in Paediatrics · doi:10.1159/000445832 · Cited by 9
Backeljauw, P. F., & Hwa, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-28038-7_2 · Cited by 8
Seki, Y., Yatabe, M., Suda, C., Morimoto, S., & Ichihara, A. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00447 · Cited by 9
Broeren, M. A. C., Krabbe, J. G., Boesten, L. S. M., Hokken‐Koelega, A. C. S., & de Rijke, Y. B. (2018) · Hormone Research in Paediatrics · doi:10.1159/000493133 · Cited by 10
Targeted literature review of the humanistic and economic burden of adult growth hormone deficiency
Loftus, J., Camacho‐Hübner, C., Hey‐Hadavi, J., & Goodrich, K. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1546682 · Cited by 11
Adult growth hormone deficiency in CEE region: Heterogeneity of the patient pathway
Shimon, I., Badiu, C., Bossowski, A. T., Doknić, M., Dzīvīte-Krišāne, I., Hána, V., Kollerová, J., Natchev, Е., Pfeifer, M., Szücs, N., et al. (2019) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2019.06.001 · Cited by 10
Roerink, S. H. P. P., Cocks, M. S., Wagenmakers, M. A. E. M., Rodighiero, R. P., Strauss, J. A., Shepherd, S. O., Plantinga, T. S., Thijssen, D. H. J., Hopman, M. T. E., Pereira, A. M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz286 · Cited by 10
Meienberg, F., Loher, H., Bucher, J., Jenni, S., Krüsi, M., Kreis, R., Boesch, C., Betz, M. J., & Christ, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-55942-w · Cited by 10
Quality of Life in Acromegaly and Growth Hormone Deficiency
Webb, S. M., Resmini, E., Vives, A. S., & Badia, X. C. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-317-6_12 · Cited by 8
Safety and efficacy of growth hormone treatment: GeNeSIS study in Spain
Tomás, C. L., Irigoyen, M. O., Cepas, E. C., Salvi, L., & García-Pérez, L. E. (2016) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2015.05.025 · Cited by 8
Uzunova, I., Кirilov, G., Zacharieva, S., Zlatareva, N., & Kalinov, K. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-100114 · Cited by 8
Bioelectrical impedance spectroscopy in growth hormone-deficient adults
Tengvall, M., Ellegård, L., Bosaeus, N., Isaksson, M., Johannsson, G., & Bosaeus, I. G. (2009) · Physiological Measurement · doi:10.1088/0967-3334/31/1/005 · Cited by 7
GH secretion reserve in subclinical hypercortisolism
Palmieri, S., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Cairoli, E., Zhukouskaya, V. V., Beck-Peccoz, P., Scillitani, A., & Chiodini, I. (2013) · Pituitary · doi:10.1007/s11102-013-0528-7 · Cited by 8
Lazure, P., Bartel, R. C., Biller, B. M. K., Molitch, M. E., Rosenthal, S. M., ROSS, J. L., Bernsten, B. D., & Hayes, S. M. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-319 · Cited by 10
Self-citationThe treatment of growth disorders in childhood and adolescence
Woelfle, J., Schnabel, D., & Binder, G. (2024) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0247 · Cited by 10
Li, Y., Liu, Y., & Gou, M. (2025) · Molecules · doi:10.3390/molecules30020429 · Cited by 10
Ishii, H., Shimatsu, A., Nishinaga, H., Murai, O., & Chihara, K. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.08.005 · Cited by 7
Yang, H., Yan, K., Xu, Y., Wang, L., Zhang, Q., Gong, F., Zhu, H., Xia, W., & Pan, H. (2020) · International Journal of Endocrinology · doi:10.1155/2020/9201979 · Cited by 9
“Main clinical characteristics include low bone mineral density, sarcopenia, increased risk of metabolic syndrome, and decreased quality of life [1, 2].”
BackgroundMethodInfluentialYovich, J. L., Zaidi, S. N. S. J. H., Nguyen, M. D., & Hinchliffe, P. M. (2020) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2020.13.3.0333 · Cited by 7
Ren, Z., Wang, Y., Chen, Q., Long, J., Zhang, R., Wu, X., Qian, W., Chen, Y., Liu, D., & Ren, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671126 · Cited by 7
Bioletto, F., Parasiliti‐Caprino, M., Berton, A. M., Prencipe, N., Cambria, V., Ghigo, E., Grottoli, S., & Gasco, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737947 · Cited by 8
Yeoh, P., Dwyer, A. A., Anghel, E., Bouloux, P. M., Khoo, B. C. E., Chew, S., Wernig, F., Carroll, P., Aylwin, S. J. B., Baldeweg, S. E., et al. (2022) · International Journal of Endocrinology · doi:10.1155/2022/7360282 · Cited by 8
Yuen, K. C. J., Birkegård, A. C., Blevins, L. S., Clemmons, D. R., Hoffman, A. R., Kelepouris, N., Kerr, J. M., Tarp, J. M., & Fleseriu, M. (2022) · International Journal of Endocrinology · doi:10.1155/2022/7853786 · Cited by 8
“Growth hormone deficiency (GHD) can develop and persist from childhood into adulthood, or be newly acquired in adulthood [2].”
BackgroundMethodInfluentialSelf-citationKwon, H., Roh, E., Ahn, C. H., Kim, H. K., Ku, C. R., Jung, K. Y., Lee, J. H., Kim, E. H., Suh, S., Hong, S., et al. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1627 · Cited by 8
Radiation-induced hypopituitarism in children with acute lymphoblastic leukemia
Mirouliaei, M., Shabani, M., Bakhshi, F., & Ordouei, M. (2013) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.113396 · Cited by 7
Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency
Kim, J. H., Cho, J. H., Yoo, H.-W., & Choi, J. H. (2014) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2014.19.1.32 · Cited by 7
Elbornsson, M., Götherström, G., Bengtsson, B., Johannsson, G., & Svensson, J. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.09.001 · Cited by 7
Dutta, P. R., Mahendran, B., Reddy, K. S., Ahluwalia, J., Vaiphei, K., Kochhar, R. K., Gupta, P., Srinivasan, A., Prakash, M., Mukherjee, K. K., et al. (2015) · Endocrine Connections · doi:10.1530/ec-14-0132 · Cited by 7
Assadi, M. H., Shknevsky, E., Segev, Y., & Tarasiuk, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-02843-5 · Cited by 7
Yang, H., Zhu, H., Yan, K., & Pan, H. (2017) · Hormone Research in Paediatrics · doi:10.1159/000478527 · Cited by 7
Williams, B. R., & Cho, J. S. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.04.006 · Cited by 10
Growth hormone deficiency and replacement effect on adult bone mass: A clinical update
Varlamov, E. V., McCartney, S., & Fleseriu, M. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2017.10.001 · Cited by 8
Hypopituitarism and Growth Hormone Deficiency
Burt, M. G., & Ho, K. K. Y. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00011-1 · Cited by 9
Secondary Adrenal Insufficiency and Growth Hormone Deficiency in Patients with Fibromyalgia
Gruber, L., Nanda, S., Nippoldt, T. B., Chang, A. Y., & Bancos, I. (2021) · Journal of Pain Research · doi:10.2147/jpr.s302291 · Cited by 9
Adult growth hormone deficiency: to treat or not to treat
Tzanela, M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.6.787 · Cited by 8
Şimşek, Y., Kaya, M. G., Tanrıverdi, F., Çalapkorur, B., Diri, H., Karaca, Z., Unluhizarci, K., & Keleştimur, F. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0142-1 · Cited by 8
The Adrenals and Pituitary—Stress, Adaptation, and Longevity
Timiras, P. S., & Gersten, O. (2007) · CRC Press eBooks · doi:10.3109/9781420007091-15 · Cited by 7
Growth Hormone and Bone: Preclinical and Clinical Perspectives
Yuen, K. C. J. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.005 · Cited by 11
The endocrine spectrum of Rathke cleft cysts
Rzewuska, N., Kunicki, J., & Kunicki, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1630695 · Cited by 8
Growth hormone treatment in aged patients with comorbidities: A systematic review
Tausendfreund, O., Bidlingmaier, M., Martini, S., Müller, K. J., Rippl, M., Schilbach, K., Schmidmaier, R., & Drey, M. (2024) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2024.101584 · Cited by 7
Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
Kuliczkowska-Płaksej, J., Zdrojowy-Wełna, A., Jawiarczyk-Przybyłowska, A., Gojny, Ł., & Bolanowski, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09878-w · Cited by 6
Bolier, M., de Winter, D. T. C., Pluimakers, V. G., Fiocco, M. F., van den Berg, S. A. A., Bresters, D., Broeder, E. V. D., der Loo, M. V. D. H., Hoefer, I. E., Janssens, G. O. R. J., et al. (2025) · Cancer · doi:10.1002/cncr.35681 · Cited by 11
Hoffman, A. R., Raveendran, S., Manjelievskaia, J., Komirenko, A., Winer, I. H., Cheng, J., Bonafede, M., Winer-Jones, J. P., Miner, P., & Smith, A. R. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03188-6 · Cited by 9
Disfunción neuroendocrina y agresión cerebral. Reunión de consenso
Leal‐Cerro, A., Rincón, M. D., & Puig‐Domingo, M. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)71944-8 · Cited by 10
Diazzi, C., Brigante, G., Ferrannini, G., Ansaloni, A., Zirilli, L., Santis, M. C. D., Zona, S., Guaraldi, G., & Rochira, V. (2016) · Endocrine · doi:10.1007/s12020-016-1133-0 · Cited by 6
Immunological and microbiological periodontal profiles in isolated growth hormone deficiency
de Araujo, I. M. P., Albuquerque‐Souza, E., Aguiar-Oliveira, M. H., Holzhausen, M., Oliveira-Neto, L. A., Salvatori, R., Saraiva, L. M., Mayer, M. P. A., Pannuti, C. M., Ribeiro, A., et al. (2018) · Journal of Periodontology · doi:10.1002/jper.17-0687 · Cited by 6
Li, J., Pan, W., Qian, J., Ni, Y., Fu, J., & Ni, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.864058 · Cited by 6
Prodam, F., Caputo, M., Romanisio, M., Brasili, S., Zavattaro, M., Samà, M. T., Ferrero, A., Costelli, S., Lenzi, F. R., Petri, A., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01975-4 · Cited by 6
“On the other hand, for diseases as obesity or growth hormone deficiency (GHD), the lack of adequate care does not entail an immediate risk of life for the patient, but could have an impact in the long term, with a reduction in quality of life, and early or late comorbidities in adulthood [10, 11].”
BackgroundVergani, E., Bruno, C., Gavotti, C., Oliva, A., Currò, D., & Mancini, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01974-5 · Cited by 6
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety
Tritos, N. A. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101790 · Cited by 6
Growth hormone and radiation therapy: friend, foe, or both?
Bahamondes, V., & Wu, S. (2024) · Endocrine Related Cancer · doi:10.1530/erc-22-0371 · Cited by 8
Evaluation of growth hormone deficiency in women with unexplained infertility
Ortac, M. S., Hacıoğlu, A., Uludağ, S. Z., Karaca, Z., Ünlühızarcı, K., Keleştimur, F., & Tanrıverdi, F. (2024) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2024.101571 · Cited by 6
Management of common endocrine conditions other than diabetes mellitus during ramadan fasting
Beshyah, S., Fiad, T. M., & Saadi, H. (2012) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/1947-489x.210770 · Cited by 6
Terapia sustitutiva a largo plazo del déficit de hormona de crecimiento en la edad adulta
Cabo, D., Lecube, A., Barrios, M., & Mesa, J. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2010.07.030 · Cited by 7
Zaninelli, D. C. T., Meister, L. H. F., Radominski, R. B., Borba, V. Z. C., de Souza, A. M., & Boguszewski, C. L. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500021 · Cited by 9
Beneficios y riesgos de la hormona del crecimiento en adultos con déficit de la misma
Díez, J. J., & Cordido, F. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2013.11.026 · Cited by 7
The Epidemiology of Growth Hormone Deficiency
Stochholm, K., & Christiansen, J. S. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-317-6_8 · Cited by 7
“Overall, the treatment is considered safe, with the precaution of not treating patients with active malignancy [ 4 ].”
BackgroundInfluentialSanchez-Garrido, M. A., Ruíz-Pino, F., Pozo-Salas, A. I., Castellano, J. M., Vazquez, M. J., Luque, R. M., & Tena‐Sempere, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70898-y · Cited by 7
Ferone, D., Profka, E., Gasco, V., Ambrosio, M. R., Colao, A., Somma, C. D., Puxeddu, E., Arnaldi, G., Pagano, C., Zecchi, E., et al. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0604-8 · Cited by 6
Mauras, N., de Pijem, L. G., Hsiang, H. Y., Desrosiers, P., Rapaport, R., Schwartz, I. D., Klein, K. O., Singh, R., Miyamoto, A., & Bishop, K. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000318075.07635.d8 · Cited by 6
Growth hormone and anabolic steroids: athletes are the tip of the iceberg
Perls, T. T. (2009) · Drug Testing and Analysis · doi:10.1002/dta.87 · Cited by 6
Les enfants guéris d’une leucémie aiguë lymphoblastique qui deviennent adultes
Tabone, M., & Leverger, G. (2009) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32442-2 · Cited by 6
Sansone, A., & Romanelli, F. (2021) · Human Aging · doi:10.1016/b978-0-12-822569-1.00007-x · Cited by 5
Motorykin, I., Mu, J., Miller, B. S., Li, A., Clarke, N. J., McPhaul, M. J., & Wu, Z. R. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0709 · Cited by 5
Donald, D. M., Tomkins, M., O'Connell, L., Fitzpatrick, D. A., Faul, C. M., O’Reilly, M., Bennett, K., & Sherlock, M. (2025) · Clinical Endocrinology · doi:10.1111/cen.15216 · Cited by 7
Mild traumatic brain injury as a cause of adult growth hormone deficiency: Diagnosis and treatment
Herodes, M., Legaspi, A., & Garcia, J. M. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101818 · Cited by 5
Clinical manifestations and treatment of hypopituitarism due to traumatic brain injury
Zhang, C. D., & Ioachimescu, A. G. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.101996 · Cited by 5
Gasco, V., Roncoroni, L., Zavattaro, M., Bona, C., Berton, A. M., Ghigo, E., Maccario, M., & Grottoli, S. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01100-y · Cited by 5
Mancini, A., Vergani, E., Bruno, C., Giavoli, C., Spaziani, M., Isidori, A. M., Arosio, M., & Pontecorvi, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1298775 · Cited by 7
Yang, H., Chen, M., Xu, H., Zhen, Y., Zhang, Y., Wang, L., Duan, L., Gong, F., Zhu, H., & Pan, H. (2024) · Endocrine · doi:10.1007/s12020-024-03786-4 · Cited by 6
Moosig, F., Reinhold‐Keller, E., Holl‐Ulrich, K., Feller, A. C., Bley, T. A., Holle, J. U., Zwerina, J., Lamprecht, P., Dalhoff, K., Venhoff, N., et al. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-012-0988-6 · Cited by 7
Moock, J., Friedrich, N., Völzke, H., Spielhagen, C., Nauck, M. A., Kołtowska‐Häggström, M., Buchfelder, M., Wallaschofski, H., & Kohlmann, T. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.07.005 · Cited by 8
“Response should be evaluated by monitoring biochemistries (IGF-I, glucose, lipids), weight and body composition, whereas in the current consensus guidelines the assessment of HRQoL has been ranked as important but does not necessarily require a questionnaire [32].”
MethodOsteoporosis: Diagnosis and Management
Ward, L. M., & Ma, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_24 · Cited by 6
Yang, H., Zhang, M.-Q., Pan, H., & Zhu, H. (2016) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(16)30046-3 · Cited by 5
Höybye, C., Weber, M. M., Pournara, E., Pedersen, B. T., & Biller, B. M. K. (2017) · Clinical Endocrinology · doi:10.1111/cen.13330 · Cited by 5
Höybye, C., Faseh, L., Himonakos, C., Pielak, T., & Eugen‐Olsen, J. (2019) · Endocrine Connections · doi:10.1530/ec-19-0159 · Cited by 6
Is biochemical hypoglycemia necessary during an insulin tolerance test?
Şimşek, Y., Karaca, Z., Diri, H., Tanrıverdi, F., Ünlühızarcı, K., & Keleştimur, F. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000200 · Cited by 7
Assessment of Levels of Metabolic Hormones and Lipid Profile in Growth Hormone Deficient Patients
Al-hindawi, G. K., Al-Lami, M. Q., & Al-Samarriae, A. Y. (2020) · Iraqi Journal of Science · doi:10.24996/ijs.2020.61.4.4 · Cited by 5
Arosio, M., Arnaldi, G., Gasco, V., Giavoli, C., Puxeddu, E., Vettor, R., Ambrosio, M. R., Gallinari, P., Zouater, H., Fedeli, P., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01308-3 · Cited by 5
Cattoni, A., Molinari, S., Medici, F., Lorenzo, P. D., Valsecchi, M. G., Masera, N., Adavastro, M., & Biondi, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.599302 · Cited by 5
Mancini, A., Guidi, F., Bruno, C., Angelini, F., Vergani, E., Lanza, P., Mordente, A., Meucci, E., & Silvestrini, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248971 · Cited by 5
Sexual Dysfunction in Sheehan Syndrome
Mandal, S., Mukhopadhyay, P., & Ghosh, S. K. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.07.013 · Cited by 5
TransCon human growth hormone for children with growth hormone deficiency: a technology evaluation
dos Santos, J. B. R., & da Silva, M. R. R. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2027365 · Cited by 5
“ectopic posterior pituitary and septo-optic dysplasia, are among the congenital causes [2,3].”
BackgroundO’Neill, C., Gangat, M., & Radovick, S. (2022) · Endocrines · doi:10.3390/endocrines3040060 · Cited by 8
Effect of GH Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels
Seki, Y., Morimoto, S., Bokuda, K., Watanabe, D., Yamashita, K., Takano, N., Amano, K., Kawamata, T., & Ichihara, A. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad137 · Cited by 5
Dlesk, A., Kamenský, G., Lazúrová, I., Kužma, M., & Payer, J. (2014) · Wiener klinische Wochenschrift · doi:10.1007/s00508-014-0536-2 · Cited by 5
Pituitary Transcription Factor Mutations Leading to Hypopituitarism
Gergics, P. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_13 · Cited by 5
Cenci, M. C. P., Soares, D. V., Spina, L. D. C., Brasil, R. R. L. O., Lobo, P. M., Micmacher, E., Vaisman, M., Boguszewski, C. L., & Conceição, F. L. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.04.002 · Cited by 6
“Serum levels of IGF-1 have been used as a biochemical marker of GH therapy in adults with GHD, despite that a substantial number of GHD patients show normal levels of IGF-1 at diagnosis [8].”
BackgroundInfluentialRavinovich, I. H., Obiols, G., Vela, E. T., Webb, S. M., Bauset, M. C., Peral, A. G., Morante, T. L., Esteban, B. M., Fernández, C. P., Pico, A. M., et al. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71403-1 · Cited by 5
Lim, H. H., Kang, M. J., Yun, I. S., Lee, Y. A., Shin, C. H., & Yang, S. W. (2010) · Korean Journal of Pediatrics · doi:10.3345/kjp.2010.53.10.892 · Cited by 5
T, R. M. C. (2015) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000211 · Cited by 5
Hypopituitarism and Growth Hormone Deficiency in Adults
Llahana, S., Marland, A., Pantovic, M., & POPOVIC, V. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_25 · Cited by 5
Current aspects of diagnosis and treatment of adult GH-deficiency
Lutsenko, A. S., Nagaeva, E. V., Belaya, Z. E., Chukhacheva, O. S., Zenkova, T. S., & Mel'nichenko, G. A. (2019) · Problems of Endocrinology · doi:10.14341/probl10322 · Cited by 7
“В настоящее время в качестве диагностического значения стимулированной секреции СТГ при гипогликемии используется диапазон 3,0–5,0 нг/мл [22, 24].”
InfluentialHaria, J., Singh, N. K., Kumar, J., Jain, S. K., & Pamidimarri, D. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115697 · Cited by 6
IGF‐1 as screening tool for acromegaly and adult‐onset growth hormone deficiency in the Netherlands
Postma, M. R., van Beek, A. P., van der Klauw, M. M., Lentjes, E. G. W. M., & Kobold, A. C. M. (2023) · Clinical Endocrinology · doi:10.1111/cen.15000 · Cited by 7
“17,18 In addition, GHRT has proven to be safe in terms of de novo cancer risk and pituitary tumour recurrence.”
BackgroundYang, H., Chen, M., Jiang, L., Wang, L., Duan, L., Gong, F., Zhu, H., & Pan, H. (2024) · Endocrine Connections · doi:10.1530/ec-24-0424 · Cited by 4
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.